← Open Payments lookup

MATTHEW COTTON: Open Payments

NPI 1376914101 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,045 in 49 payments from 13 companies in 2025. Trend: 2023 $258 · 2024 $156 · 2025 $1,045

Food & beverage: $1,045
CompanyPaymentsAmount
Novo Nordisk Inc13$235
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$183
ABBVIE INC.11$177
Lilly USA, LLC7$124
Medtronic, Inc.1$110
AstraZeneca Pharmaceuticals LP3$54
Antares Pharma, Inc.2$36
Kowa Pharmaceuticals America, Inc.2$32
Otsuka America Pharmaceutical, Inc.1$25
Phathom Pharmaceuticals, Inc.2$19

Products named: CAPLYTA, MOUNJARO, Wegovy, VRAYLAR, SYMPLICITY G3, Ozempic, Rybelsus, QULIPTA.

Industry payments across TX — which companies pay providers there.